Getinge Interim Report January-March 2025: Strong sales and improved earnings – continued focus on customer value and profitability going forward
GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 6.2% while the order intake rose by 2.9% organically. The performance in the quarter was mainly driven by...
GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY
HO CHI MINH CITY, April 22, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have entered into a strategic collaboration. The collaboration was formalized with the signing of a Memorandum of Understanding (MoU) during Element Biosciences' visit to Gene Solutions'...
Tianlong Showcases Innovation at Prestigious International Biomedical Forum in Kazakhstan
KARAGANDA, Kazakhstan, April 22, 2025 /PRNewswire/ -- Tianlong Science and Technology is honored to have been invited to speak at the "International Biomedical Forum: Researches and Innovations", held on April 17–18, 2025, at Karaganda Medical University in Kazakhstan. In addition to presenting at the forum, the Tianlong team also conducted site visits and market research activities in Kazakhstan, further...
Celebrate Earth Day with Angel Yeast: Leading the Green Production Revolution with a Zero-Carbon Factory
YICHANG, China, April 22, 2025 /PRNewswire/ -- The theme for the 56th Earth Day in 2025 is "OUR POWER, OUR PLANET," inviting everyone around the globe to unite behind renewable energy, and to triple the global generation of clean electricity by 2030. ANGEL YEAST(DEHONG) CO., LTD (SH 600298) has echoed the Earth...
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year
Firm commitment to tackling climate change in support of United Nations Sustainable Development Goals Earth Day 2025 - Our Power, Our Planet, Contribute to a sustainable future SHANGHAI, April 22, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by CDP, the...
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab
EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ -- Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has received Investigational Medicinal Product Dossier (IMPD) approval from the European Medicines Agency (EMA) to initiate a Phase 1 clinical trial of OT-C001, an allogeneic...
Docquity and AstraZeneca’s Patient Support Program Educates Tens of Thousands in Thailand
OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration helps tackle Southeast Asia's healthcare needs, with 85.7% of doctors noting immunization rates could improve with patient support (Docquity Pulse Check) BANGKOK, April 22, 2025 /PRNewswire/ -- Docquity, Southeast...
Chula’s Breakthrough Arto Sucrose-reduces Tech Cuts Sugar in Fruits by 65% and Converts to Prebiotics for Healthier Eating
BANGKOK, April 22, 2025 /PRNewswire/ -- Professor Dr. Supaart Sirikantaramas, a lecturer at the Department of Biochemistry, Faculty of Science, and the Center of Excellence in Molecular Crop, Chulalongkorn University, has developed Arto Sucrose-Reduced Technology—a groundbreaking enzyme-based innovation that transforms sucrose in fruits into prebiotics. This technology enables up to a 65% reduction in sugar content while preserving essential nutrients, making high-sugar fruits...
Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations
HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart therapies, has announced financial results for the year ended December 31, 2024 ("the Year"), demonstrating significant improvements in profitability and operational discipline despite market challenges. Key Financial Highlights Revenue:...
FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA
CARDIFF-BY-THE-SEA, Calif., April 22, 2025 /PRNewswire/ -- Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of $40 million in Series A financing. The round includes $20 million in new capital and the conversion of $20 million in seed-round debt. Participants include several leading...
